Insights

Strategic Collaboration Model Anixa’s model of partnering with top-tier research centers across development stages signals a strong openness to co-development licensing and strategic alliances with pharma or CROs to advance ovarian and breast cancer vaccines and CER-T therapies.

Early-stage Growth Needs As a clinical-stage company with minimal revenue, Anixa may require outsourced clinical manufacturing, GMP-grade analytics, and other CRO/CDMO services to progress trials, presenting outsourcing opportunities for vaccine and cellular therapy programs.

Immunotherapy Platform The CER-T ovarian cancer program and cancer vaccine portfolio offer avenues for platform licensing, co-development, or joint commercialization with partners seeking to augment their immuno-oncology pipelines.

IP Licensing Potential Recent IP activity, including a Notice of Allowance for the breast cancer vaccine tech, creates potential for licensing deals, regional rights, or co-development agreements to accelerate clinical and regulatory timelines.

Investor and BD Outreach Active attendance at investor conferences suggests a readiness to engage strategic investors and potential BD partners; tailor outreach to institutions and biopharma players seeking cancer vaccines and CAR-T/cell therapy assets.

Similar companies to Anixa Biosciences, Inc.

Anixa Biosciences, Inc. Tech Stack

Anixa Biosciences, Inc. uses 8 technology products and services including Google Ads, Amazon CloudFront, RSS, and more. Explore Anixa Biosciences, Inc.'s tech stack below.

  • Google Ads
    Advertising
  • Amazon CloudFront
    Content Delivery Network
  • RSS
    Content Management System
  • Modernizr
    Javascript Libraries
  • FingerprintJS
    Javascript Libraries
  • PWA
    Miscellaneous
  • YouTube
    Video Players
  • Apache
    Web Servers

Media & News

Anixa Biosciences, Inc.'s Email Address Formats

Anixa Biosciences, Inc. uses at least 1 format(s):
Anixa Biosciences, Inc. Email FormatsExamplePercentage
FLast@anixa.comJDoe@anixa.com
59%
First-Last@anixa.comJohn-Doe@anixa.com
17%
F.Last@anixa.comJ.Doe@anixa.com
12%
Last@anixa.comDoe@anixa.com
12%

Frequently Asked Questions

Where is Anixa Biosciences, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Anixa Biosciences, Inc.'s main headquarters is located at 3150 Almaden Expressway Suite 250 San Jose, California 95118 United States. The company has employees across 2 continents, including North AmericaAsia.

What is Anixa Biosciences, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Anixa Biosciences, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Anixa Biosciences, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Anixa Biosciences, Inc.'s official website is anixa.com and has social profiles on LinkedIn.

What is Anixa Biosciences, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Anixa Biosciences, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Anixa Biosciences, Inc. have currently?

Minus sign iconPlus sign icon
As of June 2026, Anixa Biosciences, Inc. has approximately 12 employees across 2 continents, including North AmericaAsia. Key team members include President: M. C.President: R. B.Director: E. G. G.. Explore Anixa Biosciences, Inc.'s employee directory with LeadIQ.

What industry does Anixa Biosciences, Inc. belong to?

Minus sign iconPlus sign icon
Anixa Biosciences, Inc. operates in the Biotechnology Research industry.

What technology does Anixa Biosciences, Inc. use?

Minus sign iconPlus sign icon
Anixa Biosciences, Inc.'s tech stack includes Google AdsAmazon CloudFrontRSSModernizrFingerprintJSPWAYouTubeApache.

What is Anixa Biosciences, Inc.'s email format?

Minus sign iconPlus sign icon
Anixa Biosciences, Inc.'s email format typically follows the pattern of FLast@anixa.com. Find more Anixa Biosciences, Inc. email formats with LeadIQ.

When was Anixa Biosciences, Inc. founded?

Minus sign iconPlus sign icon
Anixa Biosciences, Inc. was founded in 1982.
Anixa Biosciences, Inc. logo

Anixa Biosciences, Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

Anixa Biosciences, Inc. is a clinical-stage biotechnology company based in San Jose, California, focused on the treatment and prevention of cancer. Its therapeutic program for ovarian cancer is developed in collaboration with Moffitt Cancer Center and uses a chimeric endocrine receptor-T cell approach. The company is also developing cancer vaccines with Cleveland Clinic to address breast and ovarian cancers, plus additional vaccines aimed at other high-incidence cancers such as those of the lung, colon, and prostate. Anixa emphasizes partnerships with leading research institutions to advance technologies through development toward potential commercialization. In April 2026, the company announced that its leadership would participate in two investor conferences, signaling ongoing engagement with the investment community.

Section iconCompany Overview

Headquarters
3150 Almaden Expressway Suite 250 San Jose, California 95118 United States
Phone number
Website
anixa.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1982
Employees
11-50

Section iconFunding & Financials

  • $1M

    Anixa Biosciences, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Anixa Biosciences, Inc.'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.